
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond.
By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine.
FEATURED INSIGHTS
-
Deep Interpretation Of GMP Product Quality
Explore the critical aspects of GMP-grade raw materials in cell and gene therapy manufacturing, including contamination control, aseptic strategies, quality systems, supply chain security, and regulatory compliance.
-
CAR Expression Detection Using Fluorescent Labeled Proteins, Flow Cytometry
Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.
-
High-Sensitivity Residual E. coli DNA Testing Supporting Biologics, CGT Development
Advancements in high-sensitivity residual DNA testing enhance the precision of plasmid DNA purity analysis, ensuring compliance with regulatory standards critical for manufacturing processes.
-
Developing A Scalable Protocol For T Cell Activation, Expansion
Explore a scalable protocol for T cell activation and expansion, designed to enhance immunotherapy workflows. This approach ensures robust T cell growth, viability, and memory phenotypes for clinical applications.
-
CD8+ Single Positive T Cell Differentiation From HiPSC With A Feeder-Free System In Vitro
Learn about a feeder-free method to differentiate CD8+ single positive T cells from human induced pluripotent stem cells, which offers promising advancements for scalable and efficient cell therapies.
-
Scalable iPSC Differentiation To Natural Killer Cells With Cytotoxic Potential
Explore an innovative serum-free method to differentiate induced pluripotent stem cells (iPSCs) into natural killer (NK) cells, offering scalable solutions for immunotherapy with enhanced cytotoxic potential.
-
Raw Materials Considerations When Manufacturing CGTs And Other Biologics
Discover key considerations for qualifying GMP raw materials in cell and gene therapy manufacturing, emphasizing quality control, supplier selection, and regulatory compliance to ensure therapeutic safety and efficacy.
CONTACT INFORMATION
ACROBiosystems
1 Innovation Way
Newark, DE 19711
UNITED STATES
Phone: +1 800-810-0816
FEATURED SOLUTIONS

Learn about comprehensive solutions for cell therapy quality control, including CAR/TCR detection, residual testing, and potency assays, ensure stability, multi-batch validation, and adherence to strict quality standards.

Enhance cell therapy workflows with cutting-edge closed-system solutions that simplify processes and support consistent cell growth from research to commercial production.